These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma. Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602 [TBL] [Abstract][Full Text] [Related]
8. [Effect of STAT3 phosphorylation and p53 expression on human epidermal non melanoma cutaneous tumors]. Cai SQ; Chen LR; Wang HJ; Yao LF; Zheng M Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 33(4):331-4. PubMed ID: 15269985 [TBL] [Abstract][Full Text] [Related]
9. Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases. Liu H; Takeuchi S; Moroi Y; Lin N; Urabe K; Kokuba H; Imafuku S; Dainichi T; Uchi H; Furue M; Tu Y Int J Dermatol; 2007 Nov; 46(11):1171-6. PubMed ID: 17988337 [TBL] [Abstract][Full Text] [Related]
10. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin. Sakiz D; Turkmenoglu TT; Kabukcuoglu F Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853 [TBL] [Abstract][Full Text] [Related]
12. The role of p53, Ki-67 and laminin expression in the differential diagnosis of keratoacanthoma and well-differentiated SCC. Turan G; Altun E; Aslan F; Kulahci O Indian J Pathol Microbiol; 2019; 62(4):561-565. PubMed ID: 31611440 [TBL] [Abstract][Full Text] [Related]
13. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma. Kerschmann RL; McCalmont TH; LeBoit PE Arch Dermatol; 1994 Feb; 130(2):181-6. PubMed ID: 8304756 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma. Kanzaki A; Kudo M; Ansai S; Peng WX; Ishino K; Yamamoto T; Wada R; Fujii T; Teduka K; Kawahara K; Kawamoto Y; Kitamura T; Kawana S; Saeki H; Naito Z Int J Oncol; 2016 Mar; 48(3):1007-15. PubMed ID: 26782292 [TBL] [Abstract][Full Text] [Related]
15. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors. Cain CT; Niemann TH; Argenyi ZB Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus. Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981 [TBL] [Abstract][Full Text] [Related]
17. Differences in tumor microvessel density between squamous cell carcinomas and basal cell carcinomas may relate to their different biologic behavior. Weninger W; Rendl M; Pammer J; Grin W; Petzelbauer P; Tschachler E J Cutan Pathol; 1997 Jul; 24(6):364-9. PubMed ID: 9243364 [TBL] [Abstract][Full Text] [Related]
18. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement. Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma. Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559 [TBL] [Abstract][Full Text] [Related]
20. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin. Ribeiro D; Narikawa S; Marques ME Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]